Eli Lilly and Cipla announce agreement to distribute and promote tirzepatide in India under the…
Cipla to distribute and promote Lilly’s tirzepatide as Yurpeak across India at the same price as Mounjaro, expanding access for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
diabetes treatment
Researchers identify protein IL-35 as potential diabetes treatment
New findings reveal IL-35’s role in immune protection and potential therapeutic pathway for type 1 and autoimmune diabetes
Ozempic linked with lower dementia risk, nicotine use, British study finds
The study, published in the Lancet's eClinicalMedicine journal, explored more than 100 million medical records of the U.S.…
Eli Lilly’s Mounjaro to become leading GLP-1 therapy for type 2 diabetes in NHS in UK: GlobalData
The National Institute for Health and Care Excellence (NICE) provided guidance in August 2023 explaining that where triple therapy…
Akums gets DCGI approval to launch Lobeglitazone for diabetes treatment in India
It offers a number of advantages including a higher safety profile, higher effectiveness in lower dosage, lower risk of…
USFDA issues CRL for proposed biosimilar Insulin-R: Biocon
The US Food and Drug Administration (USFDA) issues a Complete Response Letter (CRL) to convey to a company that its initial review…
With oral Semaglutide, HCPs can provide robust HbA1c control to their type-II diabetes patients
Vikrant Shrotriya, MD and CVP, Novo Nordisk India, talks to Express Pharma about the potential and opportunities that the Indian…
Zydus receives final approval from US FDA for Dapagliflozin tablets
Dapagliflozin is used with a proper diet and an exercise programme to control high blood sugar in people with type-II diabetes